Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025)

Oramed Pharmaceuticals has reported Revenue for 8 years, with the latest figure at $2.0 million in Q1 2025.

• For the quarter ending Q1 2025, Revenue changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $2.0 million, changed N/A from the prior year.
• Revenue for Q1 2025 stood at $2.0 million, up from $674000.0 in the prior quarter.
• The five-year high for Revenue was $2.7 million in Q3 2021, with the low at $666000.0 in Q1 2022.
• Historically, Revenue has averaged $1.1 million across 4 years, with a median of $678000.0 in 2022.
• The largest YoY upside for Revenue was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
• Oramed Pharmaceuticals' Revenue stood at $2.7 million in 2021, then tumbled by 66.56% to $904000.0 in 2022, then fell by 25.44% to $674000.0 in 2023, then surged by 196.74% to $2.0 million in 2025.
• The last three Revenue figures came in at $2.0 million (Q1 2025), $674000.0 (Q2 2023), and $666000.0 (Q1 2023), per Business Quant data.